Search

everythinglearnresearchcommunity

for

Search:↓

Detailed history and physical examination are crucial for diagnosing hair loss.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Trichoscopy helps diagnose and manage hair and scalp disorders in children.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Steroids are the best treatment for Alopecia Areata with few side effects.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Greying hairs may be protected from alopecia areata.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

An 82-year-old woman's hair turned white suddenly, likely due to a rare form of alopecia that targets pigmented hair.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.